Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Paid-in capital	Noncontrolling interest	Retained earnings	Treasury stock	AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Stockholders' Equity Attributable to Noncontrolling Interest					$ 10,092
Total stockholders’ equity	$ 1,252,471
Beginning Balance at Feb. 03, 2018			$ 1,033	$ 406,351		$ 2,420,552	$ (1,490,503)	$ (95,054)
Beginning balance, shares outstanding at Feb. 03, 2018			68,195				35,105
Effect on Unearned Revenue Liabilities from New Accounting Principal in Period of Adoption	6,944
Net income attributable to noncontrolling interests	4,267
Net income attributable to A&F	74,541					74,541
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	78,808
Purchase of common stock	(68,670)
Purchase of common stock, shares			2,931				2,931
Dividends ($0.80 per share)	(53,714)					(53,714)
Share-based compensation issuances and exercises	(6,937)	[1]		(22,727)		(29,779)	$ (45,569)
Share-based compensation issuances and exercises, shares			(963)				(963)
Share-based compensation expense	21,755			21,755
Derivative financial instruments, net of tax	12,542							12,542
Foreign currency translation adjustments, net of tax	(19,940)							(19,940)
Distributions to noncontrolling interests, net	(4,638)				(4,638)
Ending Balance at Feb. 02, 2019			$ 1,033	405,379		2,418,544	$ (1,513,604)	(102,452)
Ending balance, shares outstanding at Feb. 02, 2019			66,227				37,073
Stockholders' Equity Attributable to Noncontrolling Interest					9,721
Total stockholders’ equity	1,218,621
Net income attributable to noncontrolling interests	5,602
Net income attributable to A&F	39,358					39,358
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	44,960
Purchase of common stock	$ (63,542)
Purchase of common stock, shares	63,542		3,957				3,957
Dividends ($0.80 per share)	$ (51,510)					(51,510)
Share-based compensation issuances and exercises	(6,804)	[1]		(14,403)		(17,482)	$ (25,081)
Share-based compensation issuances and exercises, shares			(516)				(516)
Share-based compensation expense	14,007			14,007
Derivative financial instruments, net of tax	(1,354)							(1,354)
Foreign currency translation adjustments, net of tax	(5,080)							(5,080)
Distributions to noncontrolling interests, net	(2,955)				(2,955)
Ending Balance at Feb. 01, 2020	1,058,810		$ 1,033	404,983		2,313,745	$ (1,552,065)	(108,886)
Ending balance, shares outstanding at Feb. 01, 2020			62,786				40,514
Impact of ASC 842 Adoption on Retained Earnings	(75,165)
Stockholders' Equity Attributable to Noncontrolling Interest	12,368				12,368
Total stockholders’ equity	1,071,178
Net income attributable to noncontrolling interests	5,067
Net income attributable to A&F						(114,021)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(108,954)
Purchase of common stock	(15,172)
Purchase of common stock, shares			1,397				1,397
Dividends ($0.80 per share)	(12,556)					(12,556)
Share-based compensation issuances and exercises	(5,694)	[1]		(22,382)		(37,698)	$ (54,386)
Share-based compensation issuances and exercises, shares			(1,010)				(1,010)
Share-based compensation expense	18,682
Derivative financial instruments, net of tax	(5,616)
Foreign currency translation adjustments, net of tax	12,195
Distributions to noncontrolling interests, net	(4,751)				(4,751)
Ending Balance at Jan. 30, 2021	936,628		$ 1,033	$ 401,283		$ 2,149,470	$ (1,512,851)	$ (102,307)
Ending balance, shares outstanding at Jan. 30, 2021			62,399				40,901
Stockholders' Equity Attributable to Noncontrolling Interest	12,684				$ 12,684
Total stockholders’ equity	$ 949,312

[1] (1)    Classified within other financing activities on the Consolidated Statements of Cash Flows.